Falcon Pharmaceuticals, Ltd. manufactures and markets generic ophthalmic, otic, and nasal products. The company offers products for the treatment of glaucoma, infectives, and allergy. It also provides timolol maleate ophthalmic gel forming solutions, steroids, and combinations; and neomycin/polymyxin b/hydrocortisone otic solutions and trifluridine ophthalmic solutions. The company was founded in 1995 and is based in Fort Worth, Texas. Falcon Pharmaceuticals, Ltd. operates as a subsidiary of Novartis AG.